Module C: Establishing the Need for Mechanical Ventilation Flashcards
acute ventilatory failure
respiratory activity is absent or is insufficient to maintain adequate oxygen uptake and carbon dioxide clearance, in spite of initial therapy
CNS disorders that may lead to hypoventilation or respiratory failure
Reduced drive to breathe due to depressant drugs, brain/brainstem lesions, hypothyroidism, or idiopathic central alveolar hypoventilation
Increased drive to breathe due to increased metabolic rate (eg. Exercise), metabolic acidosis, anxiety
neuromuscular disorders that may lead to hypoventilation or respiratory failure
Paralytic disorders: myasthenia gravis, tetanus, botulism, Guillain-Barre syndrome, poliomyelitis, muscular dystrophy, ALS
Paralytic drugs (curare, nerve gas, succinylcholine, insecticides, non depolarizing NMBA’s)
Drugs that affect neuromuscular transmission (aminoglycoside ABX, long term adrenocorticoids, CCB’s)
Impaired muscle function: electrolyte imbalances, malnutrition, peripheral nerve disorders, atrophy, fatigue, chronic pulmonary disease with decreasing capacity for diaphragmatic contraction as a result of air trapping)
Disorders that increase work of breathing
Pleura occupying lesions (eg pleural effusions, hemothorax, empyema, pneumothorax)
Chest wall deformities (eg flail chest, rib fracture, kyphoscoliosis, obesity)
Increased airway resistance resulting from increased secretions, mucosal edema, bronchoconstriction, airway inflammation, or foreign body aspiration (eg asthma, emphysema, chronic bronchitis, croup, acute epiglottitis, acute bronchitis)
Lung tissue involvement (eg interstitial pulmonary fibrotic disease, aspiration, ARDS, cardiogenic pulmonary edema, drug-induced pulmonary edema)
Pulmonary vascular problems (eg pulmonary thromboembolism, pulmonary vascular damage)
Other problems (eg increased metabolic rates with acompanying pulmonary problems)
Postoperative pulmonary complications Dynamic hyperinflation (air trapping)
Vital capacity
the volume of air that can be maximally exhaled following a maximum inspiration
VC is measured in mL/kg.
Normal adult range is 65 to 75mL/kg.
Critical value that may indicate the need for getting tubed: <10-15mL/kg
Maximum inspiratory pressure
lowest (ie most negative) pressure generated during a forceful inspiratory effort against an occluded airway
MIP is measured in cm H20
Normal adult range is -100 to -50 cm H20
Critical value that may indicate the need for getting tubed: -20 to 0 cm H20
Forced expiratory volume in 1 second (FEV1)
a pulmonary function parameter that can be used to measure airway resistance
FEV1 is measured in mL/kg IBW
Normal adult range 50 to 60 mL/kg
Critical value that may indicate the need for getting tubed: <10 mL/kg
Respiratory frequency (f)
breaths per minute
Respiratory frequency is measured in breaths/minute (f)
Normal range 12 - 20
Critical value that may indicate the need for getting tubed: >35 or <10
Peak expiratory flow rate (PEF)
a good indicator of airway resistance and a patient’s ability to maintain airway patency
PEF is measured in L/min
Normal adult range 350-600 L/min
Critical value that may indicate the need for getting tubed: <75-100 L/min
Dead Space:Tidal Volume ratio
the ratio of physiologicdead spaceovertidal volume(VD/VT)
PaO2/FiO2 ratio
the ratio of arterial oxygen partial pressure(PaO2 in mmHg) to fractional inspired oxygen (FiO2 expressed as a fraction, not a percentage).
P/F ratio is measured in mmHg
Normal adult range: 400-500 mmHg
Critical value that may indicate the need for getting tubed: <300mmHg
A-a gradient
The A-a gradient can be used to determine the cause of altered oxygenation
Normal A-a gradient
Alveolar hypoventilation (elevated PACO2) Low PiO2 (FiO2 < 0.21 or barometric pressure < 760 mmHg)
Raised A-a gradient
Diffusion defect (rare) V/Q mismatch Right-to-Left shunt (intrapulmonary or cardiac)
four standard criteria for the institution of mechanical ventilatory support.
Apnea or absence of breathing
Acute ventilatory failure
Impending ventilatory failure
Refractory hypoxemic respiratory failure with increased work of breathing or an ineffective breathing pattern
physiologic goals of therapy for the mechanically ventilated patient
Support or manipulate pulmonary gas exchange
Increase lung volume
Reduce the work of breathing
clinical goals of therapy for the mechanically ventilated patient
- Reverse acute respiratory failure
- Reverse respiratory distress
- Reverse hypoxemia
- Prevent or reverse atelectasis and maintain FRC
- Reverse respiratory muscle fatigue
- Permit sedation or paralysis
- Reduce systemic or myocardial oxygen consumption
- Minimize associated complications and reduce mortality